A Biobank of Colorectal Cancer Patient-Derived Xenografts

被引:12
|
作者
Abdirahman, Suad M. [1 ,2 ]
Christie, Michael [1 ,3 ]
Preaudet, Adele [1 ]
Burstroem, Marie C. U. [1 ]
Mouradov, Dmitri [1 ,2 ]
Lee, Belinda [1 ]
Sieber, Oliver M. [1 ,2 ,4 ,5 ]
Putoczki, Tracy L. [1 ,2 ,4 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Personalised Oncol Div, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia
[3] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia
[4] Univ Melbourne, Dept Surg, Parkville, Vic 3010, Australia
[5] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
基金
英国医学研究理事会;
关键词
colon cancer; chemotherapy; model; patient-derived; xenograft; EPITHELIAL OVARIAN-CANCER; COLON-CANCER; TUMOR XENOGRAFTS; CELL-LINE; 1ST-LINE TREATMENT; STAGE-II; MODELS; ESTABLISHMENT; IDENTIFICATION; HETEROGENEITY;
D O I
10.3390/cancers12092340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) is a challenging disease, with a high mortality rate and limited effective treatment options, particularly for late-stage disease. Patient-derived xenografts (PDXs) have emerged as an informative, renewable experimental resource to model CRC architecture and biology. Here, we describe the generation of a biobank of CRC PDXs from stage I to stage IV patients. We demonstrate that PDXs within our biobank recapitulate the histopathological and mutation features of the original patient tumor. In addition, we demonstrate the utility of this resource in pre-clinical chemotherapy and targeted treatment studies, highlighting the translational potential of PDX models in the identification of new therapies that will improve the overall survival of CRC patients.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 50 条
  • [11] Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts
    Umberto Perron
    Elena Grassi
    Aikaterini Chatzipli
    Marco Viviani
    Emre Karakoc
    Lucia Trastulla
    Lorenzo M. Brochier
    Claudio Isella
    Eugenia R. Zanella
    Hagen Klett
    Ivan Molineris
    Julia Schueler
    Manel Esteller
    Enzo Medico
    Nathalie Conte
    Ultan McDermott
    Livio Trusolino
    Andrea Bertotti
    Francesco Iorio
    Nature Communications, 15 (1)
  • [12] Patient-derived xenografts of colorectal cancer for testing new pharmacological substances.
    Egorov, Georgiy Yu.
    Goncharova, Anna S.
    Khodakova, D. V.
    Kurbanova, L. Z.
    Mindar, Maria V.
    Zaikina, Ekaterina V.
    Komarova, Ekaterina Fedorovna
    Kolesnikov, Evgeniy N.
    Maksimov, Aleksey Yu.
    Katsieva, Tanzila B.
    Myagkov, Roman E.
    Averkin, Mikhail A.
    Snezhko, Aleksandr V.
    Gaziev, Umar M.
    Nikolaeva, Nadezhda V.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15612 - E15612
  • [13] Establishment of patient-derived xenografts in penile cancer
    Segarra, Luis A.
    Zacharias, Niki M.
    Pieretti, Alberto
    Alaniz, Angelita
    Maity, Tapati
    Martinez, Sue
    Rao, Priya
    Fowlkes, Natalie
    Chahoud, Jad
    Lu, Xin
    Ferrer, Magaly Martinez
    Wood, Christopher
    Pettaway, Curtis
    CANCER RESEARCH, 2022, 82 (12)
  • [14] Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data
    Nunes, Manoel
    Vrignaud, Patricia
    Vacher, Sophie
    Richon, Sophie
    Lievre, Astrid
    Cacheux, Wulfran
    Weiswald, Louis-Bastien
    Massonnet, Gerald
    Chateau-Joubert, Sophie
    Nicolas, Andre
    Dib, Colette
    Zhang, Weidong
    Watters, James
    Bergstrom, Donald
    Roman-Roman, Sergio
    Bieche, Ivan
    Dangles-Marie, Virginie
    CANCER RESEARCH, 2015, 75 (08) : 1560 - 1566
  • [15] Autologous T cell responses against patient-derived colorectal cancer xenografts.
    Chou, Jeffrey
    Mortales, Christie-Lynn L.
    Ojeaburu, Sheila
    Yeung, Raymond S. W.
    Warren, Edus H.
    CANCER RESEARCH, 2013, 73
  • [16] Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
    Lazzari, Luca
    Corti, Giorgio
    Picco, Gabriele
    Isella, Claudio
    Montone, Monica
    Arcella, Pamela
    Durinikova, Erika
    Zanella, Eugenia R.
    Novara, Luca
    Barbosa, Fabiane
    Cassingena, Andrea
    Cancelliere, Carlotta
    Medico, Enzo
    Sartore-Bianchi, Andrea
    Siena, Salvatore
    Garnett, Mathew J.
    Bertotti, Andrea
    Trusolino, Livio
    Di Nicolantonio, Federica
    Linnebacher, Michael
    Bardelli, Alberto
    Arena, Sabrina
    CLINICAL CANCER RESEARCH, 2019, 25 (20) : 6243 - 6259
  • [17] Development of patient-derived orthotopic xenografts from metastatic colorectal cancer in nude mice
    Roque-Lima, Bruno
    de Tulio Augusto Roque, Caroline Correa
    Begnami, Maria Dirlei
    Peresi, Patricia
    Pereira Lima, Eduardo Nobrega
    Lopes de Mello, Celso Abdon
    Coimbra, Felipe JoseFernandez
    Chojniak, Rubens
    Santos, Tiago Goss
    JOURNAL OF DRUG TARGETING, 2019, 27 (09) : 943 - 949
  • [18] A Chemosensitivity Study of Colorectal Cancer Using Xenografts of Patient-Derived Tumor Initiating Cells
    Maekawa, Hisatsugu
    Miyoshi, Hiroyuki
    Itatani, Yoshiro
    Kawada, Kenji
    Sakai, Yoshiharu
    Taketo, Makoto M.
    CANCER SCIENCE, 2018, 109 : 604 - 604
  • [19] Establishment of patient-derived organoid biobank of tongue cancer
    Sase, Miwako
    Sato, Taku
    Kajita, Mihoko
    Kawashima, Rie
    Ohteki, Toshiaki
    CANCER SCIENCE, 2021, 112 : 862 - 862
  • [20] Patient-derived murine xenografts
    Annette Fenner
    Nature Reviews Urology, 2015, 12 (10) : 536 - 536